Biotech Investors & VC Firms

2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BE Better Bite Ventures MMKSES5 people · Leads rounds	88🔒	—		Pre-Seed–Series A	—	+ Add to CRM
DE Detong Capital JTRSSJTL11 people	88🔒	Shanghai	CN	Seed–Late Stage	$20M	+ Add to CRM
SU Suncoast Ventures GLHWJHMR14 people	88🔒	Walnut Creek	US	Pre-Seed–Series A	—	+ Add to CRM
EV Ev3 Ventures Llc MRSG2 people · Leads rounds	88🔒	New York	US	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
BI Bison Ventures BHCATBEM7 people	88🔒	Seattle	US	Seed–Series A	—	+ Add to CRM
BO Boundary Capital MDMWDS4 people	88🔒	Northampton	GB	Pre-Seed–Growth	$190.5K – $635K	+ Add to CRM
ED Edge Case Capital Partners CMJMNSSI4 people · Leads rounds	88🔒	—	US	Pre-Seed–Seed	$25K – $100K	+ Add to CRM
GE Germin8 Ventures MLALBSCH10 people	88🔒	Chicago	US	Seed–Series B	—	+ Add to CRM
UN Undeterred Capital JWELKTPS4 people · Leads rounds	88🔒	Los Angeles	US	Pre-Seed–Seed	$500K – $1M	+ Add to CRM
AM American Century Private Investments JTBSCCJP15 people	88🔒	Kansas City	US	Growth	—	+ Add to CRM
BO Borealis Ventures DCJSPFBS12 people	88🔒	Hanover	US	Pre-Seed–Series A	$1M – $2.5M	+ Add to CRM
BU Business Growth Fund BJABAGAS9 people · Follows rounds	88🔒	London	GB	Seed–Growth	$3.8M – $38M	+ Add to CRM
DE Decacorn Capital DAAA12 people	88🔒	Singapore	SG	Seed–Series B	$300K – $600K	+ Add to CRM
GA Ganesha Lab	88🔒	Santiago	CL	Pre-Seed–Seed	$200K	+ Add to CRM
IM Impact Ventures BMEEGIÁH6 people	88🔒	Budapest	HU	Seed–Series A	$378K – $1.6M	+ Add to CRM
OR ORI Capital SSDTGSYE15 people	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	—	+ Add to CRM
TE Texas Ventures ESACAVHM6 people	88🔒	Houston	US	Seed–Late Stage	—	+ Add to CRM
TH Think.Health FKMRNB3 people	88🔒	Berlin	DE	Seed–Growth	$550K – $11M	+ Add to CRM
WA WA4STEAM BOCPEAID6 people	88🔒	Barcelona	ES	Pre-Seed–Series A	—	+ Add to CRM
AS Asia2G Capital AJAKIHJJ5 people	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
GE Gefen Capital DWDWLGSI8 people	88🔒	Herzliya Pituach	IL	Seed–Series B	—	+ Add to CRM
GI Gimv AJLTMMPV11 people · Leads rounds	88🔒	The Hague	BE	Growth–Late Stage	$21M – $430M	+ Add to CRM
MR MRL Ventures Fund PDJRKKOD5 people · Leads rounds	88🔒	Cambridge	US	Pre-Seed–Series B	$25M	+ Add to CRM
MV MVM Life Science Partners EBEFHHJT11 people	88🔒	London	GB	Seed–Late Stage	$20M – $100M	+ Add to CRM

Better Bite Ventures

Pre-Seed–Series A

MMKSES5 people

Detong Capital

ShanghaiSeed–Late Stage$20M

JTRSSJTL11 people

Suncoast Ventures

Walnut CreekPre-Seed–Series A

GLHWJHMR14 people

Ev3 Ventures Llc

New YorkPre-Seed–Series A$500K – $3M

MRSG2 people

Bison Ventures

SeattleSeed–Series A

BHCATBEM7 people

Boundary Capital

NorthamptonPre-Seed–Growth$190.5K – $635K

MDMWDS4 people

Edge Case Capital Partners

Pre-Seed–Seed$25K – $100K

CMJMNSSI4 people

Germin8 Ventures

ChicagoSeed–Series B

MLALBSCH10 people

Undeterred Capital

Los AngelesPre-Seed–Seed$500K – $1M

JWELKTPS4 people

American Century Private Investments

Kansas CityGrowth

JTBSCCJP15 people

Borealis Ventures

HanoverPre-Seed–Series A$1M – $2.5M

DCJSPFBS12 people

Business Growth Fund

LondonSeed–Growth$3.8M – $38M

BJABAGAS9 people

Decacorn Capital

SingaporeSeed–Series B$300K – $600K

DAAA12 people

Ganesha Lab

SantiagoPre-Seed–Seed$200K

Impact Ventures

BudapestSeed–Series A$378K – $1.6M

BMEEGIÁH6 people

ORI Capital

Hong KongPre-Seed–Late Stage

SSDTGSYE15 people

Texas Ventures

HoustonSeed–Late Stage

ESACAVHM6 people

Think.Health

BerlinSeed–Growth$550K – $11M

FKMRNB3 people

WA4STEAM

BarcelonaPre-Seed–Series A

BOCPEAID6 people

Asia2G Capital

Silicon ValleyPre-Seed–Series A

AJAKIHJJ5 people

Gefen Capital

Herzliya PituachSeed–Series B

DWDWLGSI8 people

Gimv

The HagueGrowth–Late Stage$21M – $430M

AJLTMMPV11 people

MRL Ventures Fund

CambridgePre-Seed–Series B$25M

PDJRKKOD5 people

MVM Life Science Partners

LondonSeed–Late Stage$20M – $100M

EBEFHHJT11 people

Data sourced from public filings and firms' own websites — see our methodology.